Drug class

Isoniazids

The term "Isoniazids" is not a formal standalone therapeutic drug class in standard regulatory classifications such as the FDA Established Pharmacologic Class (EPC) system, but rather refers to the specific antimycobacterial agent isoniazid (isonicotinic acid hydrazide) and its related hydrazide chemical analogues. Read more about Isoniazids

12 drugs in this class 11 manufacturers

Advertisement

Drugs in Isoniazids

Showing 1–9 of 12 drugs

ISONIAZID

ISONIAZIDS · PULMONARY TUBERCULOSIS ·+4
CAROLINA MED.

ISONIAZID

ISONIAZIDS · PULMONARY TUBERCULOSIS ·+4
SANDOZ

ISONIAZID

ISONIAZIDS · PULMONARY TUBERCULOSIS ·+4
CAROLINA MED.

ISONIAZID

ISONIAZIDS · PULMONARY TUBERCULOSIS ·+4
TEVA USA

ISONIAZID

ISONIAZIDS · PULMONARY TUBERCULOSIS ·+4
GSK Consumer Healthcare

ISONIAZID

ISONIAZIDS · PULMONARY TUBERCULOSIS ·+4
CHARTWELL RX LL

ISONIAZID

ISONIAZIDS · PULMONARY TUBERCULOSIS ·+4
BRYANT RANCH PR

ISONIAZID

ISONIAZIDS · PULMONARY TUBERCULOSIS ·+4
LEHIGH VALLEY T

ISONIAZID

ISONIAZIDS · PULMONARY TUBERCULOSIS ·+4
APHENA PHARMA S
Filter & compare in the drug finder → Opens the drug finder with Isoniazids preselected. Add indication or manufacturer filters there.

About Isoniazids.

The term "Isoniazids" is not a formal standalone therapeutic drug class in standard regulatory classifications such as the FDA Established Pharmacologic Class (EPC) system, but rather refers to the specific antimycobacterial agent isoniazid (isonicotinic acid hydrazide) and its related hydrazide chemical analogues.

Functioning as a prodrug activated by the bacterial enzyme KatG, isoniazid exerts potent bactericidal activity by inhibiting the enoyl-ACP reductase InhA, thereby disrupting mycolic acid synthesis essential for the mycobacterial cell wall.

Within professional therapeutics, it serves as a foundational first-line antimycobacterial agent primarily indicated for both the prevention of latent infection and the multi-drug treatment of active disease caused by *Mycobacterium tuberculosis*.